Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China
· Delayed Price · Currency is CNY 26.65
-0.53 (-1.95%)
Apr 29, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 5,378 | 4,179 | 1,660 | 2,364 | 3,356 | 4,735 | Upgrade
|
| Market Cap Growth | 16.89% | 151.73% | -29.79% | -29.56% | -29.11% | 7.30% | Upgrade
|
| Enterprise Value | 5,123 | 4,007 | 2,088 | 2,596 | 3,264 | 4,405 | Upgrade
|
| Last Close Price | 26.65 | 20.73 | 9.97 | 14.04 | 19.45 | 26.69 | Upgrade
|
| PE Ratio | 18.81 | 16.51 | - | 140.89 | 63.68 | 35.64 | Upgrade
|
| Forward PE | 23.58 | 20.53 | 20.96 | 30.44 | - | - | Upgrade
|
| PS Ratio | 3.09 | 2.49 | 1.38 | 2.32 | 3.28 | 4.75 | Upgrade
|
| PB Ratio | 2.37 | 1.91 | 1.13 | 1.57 | 2.18 | 2.93 | Upgrade
|
| P/TBV Ratio | 2.51 | 2.03 | 1.24 | 1.68 | 2.34 | 3.14 | Upgrade
|
| P/FCF Ratio | 51.95 | 29.53 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 23.07 | 17.52 | 38.13 | 25.44 | 34.72 | 30.41 | Upgrade
|
| EV/Sales Ratio | 2.94 | 2.38 | 1.74 | 2.55 | 3.19 | 4.42 | Upgrade
|
| EV/EBITDA Ratio | 11.52 | 10.02 | 15.87 | 20.45 | 26.41 | 26.89 | Upgrade
|
| EV/EBIT Ratio | 15.87 | 14.34 | 113.82 | 395.16 | 53.50 | 32.56 | Upgrade
|
| EV/FCF Ratio | 49.48 | 28.31 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.11 | 0.61 | 0.56 | 0.51 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 0.77 | 0.57 | 6.75 | 6.63 | 6.40 | 4.16 | Upgrade
|
| Debt / FCF Ratio | 3.30 | 1.62 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | -0.11 | 0.25 | 0.16 | 0.00 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.60 | -0.60 | 2.75 | 1.93 | 0.04 | -2.55 | Upgrade
|
| Net Debt / FCF Ratio | -2.59 | -1.71 | -2.39 | -2.67 | -0.01 | 0.94 | Upgrade
|
| Asset Turnover | 0.55 | 0.56 | 0.40 | 0.34 | 0.36 | 0.44 | Upgrade
|
| Inventory Turnover | 4.45 | 4.51 | 4.22 | 3.78 | 3.72 | 4.06 | Upgrade
|
| Quick Ratio | 1.50 | 1.29 | 1.08 | 1.25 | 1.42 | 2.70 | Upgrade
|
| Current Ratio | 1.93 | 1.77 | 1.42 | 1.62 | 1.68 | 3.18 | Upgrade
|
| Return on Equity (ROE) | 14.89% | 13.88% | -1.33% | 1.10% | 3.34% | 8.86% | Upgrade
|
| Return on Assets (ROA) | 6.41% | 5.80% | 0.38% | 0.14% | 1.33% | 3.76% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.44% | 13.02% | 1.03% | 0.40% | 4.13% | 12.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.10% | 12.30% | 0.90% | 0.30% | 2.80% | 6.00% | Upgrade
|
| Earnings Yield | 5.32% | 6.06% | -1.21% | 0.71% | 1.57% | 2.81% | Upgrade
|
| FCF Yield | 1.93% | 3.39% | -9.09% | -3.87% | -9.90% | -9.39% | Upgrade
|
| Dividend Yield | 1.47% | 1.45% | 1.07% | 1.92% | 1.54% | 1.24% | Upgrade
|
| Payout Ratio | 17.08% | 19.72% | - | 349.40% | 118.55% | 36.08% | Upgrade
|
| Buyback Yield / Dilution | -19.57% | -18.13% | 0.06% | -0.33% | 0.19% | -12.59% | Upgrade
|
| Total Shareholder Return | -18.15% | -16.69% | 1.12% | 1.59% | 1.74% | -11.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.